Filip Woestenborghs - Concepedia

Author

Filip Woestenborghs

Janssen (Belgium)

Also Known As

F Woestenborghs, F. Woestenborghs, Filip A. A. Woestenborghs, Filip A. A. Woestenborghs, Filip Woestenborghs

Publications

346

Citations

H-Index

Concepts

All Affiliations

Janssen (Belgium)Johnson & Johnson (United States)University of Manchester University of Aberdeen

About

Filip Woestenborghs is an author at Janssen (Belgium) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	289
2	Engineering	1	1	82
3	Natural Sciences	1	1	25
4	Public Health	1	1	41
5	Biochemistry	1	1	25

Filip Woestenborghs

Publications

339

Citations

H-Index

Page 1

	Year	Citations
Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation Frank C. Odds, Luc Vranckx, Filip Woestenborghs Antimicrobial Agents and Chemotherapy EngineeringDiagnosisClinical MycologyDrug ResistanceBioanalysis	1995	82
An assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening Jacky Van Gompel, Filip Woestenborghs, D. Beerens, Mutagenesis	2005	50
In Vitro and In Vivo Activities of the Novel Azole Antifungal Agent R126638 Frank C. Odds, Jannie Ausma, F. Van Gerven, Antimicrobial Agents and Chemotherapy Malassezia SppMedicinal ChemistryAntifungal AgentVivo ActivitiesAntifungal Agents	2004	49
Interlaboratory assessment of the GreenScreen HC GADD45a-GFP genotoxicity screening assay: An enabling study for independent validation as an alternative method Nicholas Billinton, Paul W. Hastwell, D. Beerens, Mutation Research/Genetic Toxicology and Environmental Mutagenesis Enabling StudyCancer ScreeningMedicineInterlaboratory AssessmentIndependent Validation	2008	41
Oxygen as limiting nutrient for growth of Cryptococcus neoformans Frank C. Odds, T De Backer, Géry Dams, Journal of Clinical Microbiology BiologyIndustrial MycologyRpmi 1640Growth TurbidityBioenergetics	1995	39
Pyrrolo[1,2-a][1,4]benzodiazepine: A novel class of non-azole anti-dermatophyte anti-fungal agents Lieven Meerpoel, Jef Van Gestel, F. Van Gerven, Bioorganic & Medicinal Chemistry Letters Antifungal AgentAntifungal AgentsMedicineMedicinal FungiNovel Class	2005	28
Heteroaryl urea inhibitors of fatty acid amide hydrolase: Structure–mutagenicity relationships for arylamine metabolites Mark S. Tichenor, John M. Keith, W. M. Jones, Bioorganic & Medicinal Chemistry Letters Heteroaryl Urea InhibitorsStructure–mutagenicity RelationshipsBiochemistryNatural SciencesBiocatalysis	2012	25
Synthesis and in Vitro and in Vivo Structure−Activity Relationships of Novel Antifungal Triazoles for Dermatology Lieven Meerpoel, L. J. J. Backx, Louis J. E. Van der Veken, Journal of Medicinal Chemistry Medicinal ChemistryAntifungal AgentAntifungal AgentsMedicineRare Activity	2005	25

Page 1